Mitra Ramgopal
Stock Analyst at Sidoti & Co.
(3.02)
# 1,450
Out of 5,044 analysts
21
Total ratings
73.33%
Success rate
33.14%
Average return
Main Sectors:
Stocks Rated by Mitra Ramgopal
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BCPC Balchem | Upgrades: Buy | $175 | $153.69 | +13.87% | 6 | Feb 22, 2022 | |
| TRNS Transcat | Upgrades: Buy | $60 | $74.27 | -19.21% | 2 | May 19, 2021 | |
| AMN AMN Healthcare Services | Maintains: Buy | $72 → $70 | $20.63 | +239.31% | 5 | Jun 16, 2020 | |
| ADUS Addus HomeCare | Maintains: Buy | $96 → $115 | $122.75 | -6.31% | 4 | Jun 1, 2020 | |
| USPH U.S. Physical Therapy | Maintains: Buy | $128 → $80 | $88.08 | -9.17% | 1 | Mar 27, 2020 | |
| BEAT HeartBeam | Maintains: Buy | $81 → $75 | $1.60 | +4,587.50% | 3 | Feb 27, 2020 |
Balchem
Feb 22, 2022
Upgrades: Buy
Price Target: $175
Current: $153.69
Upside: +13.87%
Transcat
May 19, 2021
Upgrades: Buy
Price Target: $60
Current: $74.27
Upside: -19.21%
AMN Healthcare Services
Jun 16, 2020
Maintains: Buy
Price Target: $72 → $70
Current: $20.63
Upside: +239.31%
Addus HomeCare
Jun 1, 2020
Maintains: Buy
Price Target: $96 → $115
Current: $122.75
Upside: -6.31%
U.S. Physical Therapy
Mar 27, 2020
Maintains: Buy
Price Target: $128 → $80
Current: $88.08
Upside: -9.17%
HeartBeam
Feb 27, 2020
Maintains: Buy
Price Target: $81 → $75
Current: $1.60
Upside: +4,587.50%